Current Status and Role of Patient-reported Outcome Measures (PROMs) in Endourology

Mehmi, Ashley; Jones, Patrick; Somani, Bhaskar

doi:10.1016/j.urology.2020.09.022

Cited by 57 publications

(33 citation statements)

References 44 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As part of the evolution for patient centred and holistic care, an increasing number of studies now include quality of life (QoL) as an outcome measure [17]. Four recent studies were identified, which explored this theme [18][19][20][21].…”

Section: Quality Of Lifementioning

confidence: 99%

Gender Differences in Kidney Stone Disease (KSD): Findings from a Systematic Review

et al. 2021

Self Cite

View full text Add to dashboard Cite

Purpose of Review The prevalence of kidney stones is rising and historically carries a preponderance for males. However, recent evidence has questioned whether this gender gap is closing. The aim of this systematic review was to examine this further as well as evaluate possible underlying causes. Recent Findings Recent evidence confirms the disparity in kidney stone disease between genders is closing. In the modern era, the rise in prevalence among females has been greater, especially in adolescence. Quality of life is also more adversely affected by kidney stone events among females who are also more likely to develop sepsis after endourological surgery. Males, however, are more likely to present with stone events during periods of high ambient temperatures Summary Recent literature demonstrates a temporal change in the disease burden of KSD among men and women. The latter, especially adolescent females, are more likely to develop KSD in their lifetime compared to previous eras. Determining causation is complex and continued research is warranted.

show abstract

Section: Quality Of Lifementioning

confidence: 99%

Gender Differences in Kidney Stone Disease (KSD): Findings from a Systematic Review

et al. 2021

Self Cite

View full text Add to dashboard Cite

show abstract

“…those suggested by the EAU) and ‘all’ indications for intervention in their study [11,30,31,35]. It is recognised that these aforementioned objective measures are not the sole reason patients have active management of KSD and that patient‐reported outcome measures (PROMs) also contribute to patient management, as well as patient preference [40]. The Cambridge Renal Stone PROM (CReSP) has been developed and validated for use in KSD with six domains pertaining to quality of life [41].…”

Section: Discussionmentioning

confidence: 99%

“…2 Included studies and their timing of reported symptom-related outcomes ( • mean, ▲ median) [26][27][28][29][30][31][32][33]. management, as well as patient preference [40]. The Cambridge Renal Stone PROM (CReSP) has been developed and validated for use in KSD with six domains pertaining to quality of life [41].…”

Section: Discussionmentioning

confidence: 99%

Natural history of small asymptomatic kidney and residual stones over a long‐term follow‐up: systematic review over 25 years

et al. 2021

View full text Add to dashboard Cite

Objective To systematically review the natural history of small asymptomatic kidney and residual stones, as the incidental identification of small, asymptomatic renal calculi has risen with increasing use of high‐resolution imaging. Materials and methods We reviewed the natural history of small asymptomatic kidney and residual stones using the Cochrane and Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) methodology. We searched MEDLINE, Scopus, EMBASE, EBSCO, Cochrane library and Clinicaltrials.gov using themes of ‘asymptomatic’, ‘nephrolithiasis’, ‘observation’, ‘symptoms’, ‘admission’, ‘intervention’ and similar allied terms for all English language articles from 1996 to 2020 (25 years). Inclusion criteria were studies with ≥50 patients, stones ≤10 mm, and a mean follow‐up of ≥24 months. Primary outcomes were occurrence of symptoms, emergency admission, and interventions. Results Our literature search returned 2247 results of which 10 papers were included in the final review. Risk of symptomatic episodes ranged from 0% to 59.4%. Meta‐analysis did not identify any significant difference in the likelihood of developing symptoms when comparing stones <5 mm to those >5 mm, nor those <10 mm to those >10 mm. Risk of admission varied from 14% to 19% and the risk of intervention from 12% to 35%. Meta‐analysis showed a significantly decreased likelihood of intervention for stones <5 vs >5 mm and <10 vs >10 mm. Studies had variable risk of bias due to heterogeneous reporting of outcome measures with significant likelihood that observed differences in results were compatible with chance alone (Symptoms: I2=0%, Cochran’s Q = 3.09, P = 0.69; Intervention: I2=0%, Cochran’s Q = 1.76, P = 0.88). Conclusions The present systematic review indicates that stone size is not a reliable predictor of symptoms; however, risk of intervention is greater for stones >5mm vs <5 mm and >10 vs <10 mm. This review will inform urologists as they discuss management strategies with patients who have asymptomatic renal stones and offer insight to committees during the development of evidence‐based guidelines.

show abstract

“…It is worth noting that the timeline of this system is a rough schedule that can dynamically change according to local conditions. The limitations of this system are as follows: on the one hand, it does not consider the patients' demographic factors, such as lung disease or cardiovascular disease; on the other hand, it was developed and tested in only one medical center, which was not in an epidemic area and did not face the threat of resource shortages; furthermore, the evaluation of the symptoms was subjective, whether need to incorporate the objective measures such as patient reported outcome measures (PROMs), [30] worth further research.…”

Section: Discussionmentioning

confidence: 99%

The development and application of a triage system for urolithiasis during COVID-19

Chen

Ren

2021

World J Urol

View full text Add to dashboard Cite

Current Status and Role of Patient-reported Outcome Measures (PROMs) in Endourology

Cited by 57 publications

References 44 publications

Gender Differences in Kidney Stone Disease (KSD): Findings from a Systematic Review

Gender Differences in Kidney Stone Disease (KSD): Findings from a Systematic Review

Natural history of small asymptomatic kidney and residual stones over a long‐term follow‐up: systematic review over 25 years

The development and application of a triage system for urolithiasis during COVID-19

Contact Info

Product

Resources

About